During their visit to Roatan, Honduras, Kenneth Scott and his wife Christine Scott had a specific
purpose in mind: to explore the pioneering work of Minicircle, a method development company in the
field of genetic enhancement. Minicircle has achieved a remarkable milestone by developing the
world’s first reversible human genetic enhancement platform. This platform utilizes highly expressive
DNA plasmids to introduce new genes into the human body, all while keeping the existing genome
unaltered.
The Results
Christine’s visit to Minicircle in Roatan signifies her proactive approach to exploring cutting-edge
advancements in genetic therapies. By seeking out Minicircle’s expertise, she had the opportunity to
learn about their revolutionary reversible plasmid platform.This platform offers a non-inflammatory and non-heritable approach to gene therapy, ensuring safety and minimizing long-term implications.
The visit to Minicircle underscores the Scotts’ commitment to pushing the boundaries of medical
science and embracing innovative solutions for improved health and well-being. Through their
exploration of Minicircle’s genetic enhancement platform, they contribute to the ongoing progress in the field of gene therapy, reimagining the future of human potential and paving the way for advancements
in genetic interventions.